Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor

2014436 citationsJournal Articlehybrid Open Access

Authors

NCT01172938.

Good health and well-being

Published in: Annals of the Rheumatic Diseases

Volume 73, Issue 6, pp. 1020-1026

Field-Weighted Citation Impact: 47.17